Plasma Levels of Magnesium, Calcium, Calcium to Magnesium Ratio, and Associations with Metabolic Syndrome and Cardiometabolic Risk Factors
Authors:
- Melissa Nunes MoiaMMMelissa Nunes Moia
- Severina Carla Vieira Cunha LimaSLSeverina Carla Vieira Cunha Lima
- Francisca Leide da Silva NunesFNFrancisca Leide da Silva Nunes
- Salomão Israel Monteiro Lourenço QueirozSQSalomão Israel Monteiro Lourenço Queiroz
- Dirce Maria Lobo MarchioniDMDirce Maria Lobo Marchioni
- Lucia Fátima Campos PedrosaLucia Fátima Campos Pedrosa
- Fernando BarbosaFBFernando Barbosa
- Clélia de Oliveira LyraCLClélia de Oliveira Lyra
- Karine Cavalcanti Maurício Sena-EvangelistaKarine Cavalcanti Maurício Sena-Evangelista
- 12 February 2024
- journal article
- research article
- Published by Springer Nature in Biological Trace Element Research
- Vol. 202 (12) , 5307-5318
Abstract
Magnesium and calcium are elements that have been associated with cardiometabolic risk factors related to metabolic syndrome (MetS). However, there are gaps in the knowledge regarding the impact of the calcium to magnesium (Ca/Mg) ratio in plasma. Thus, we aim to evaluate the associations between magnesium and calcium levels in plasma, and the Ca/Mg ratio in plasma with MetS components and other cardiometabolic risk factors. This cross-sectional study was carried out with 112 adults and older people, distributed into groups with (n = 60) and without MetS (n = 52). We evaluated sociodemographic, anthropometric, and biochemical data. Magnesium and calcium levels in plasma were measured by inductively coupled plasma mass spectrometry technique (ICP-MS). There was a high frequency of MetS, with no significant differences in magnesium and calcium levels and Ca/Mg ratio in plasma observed between groups. There were no associations between magnesium and MetS components or other cardiometabolic risk factors (all p > 0.05). Calcium levels were associated with total cholesterol (β = − 0.020; p = 0.000) and high-density lipoprotein cholesterol (HDL-c) (β = − 0.046; p = 0.005). The total cholesterol (β = − 0.025; p = 0.000) and low-density lipoprotein cholesterol (LDL-c) (β = 0.017; p = 0.020) were preditors of the Ca/Mg ratio. These results indicate important associations of calcium and the Ca/Mg ratio in plasma with cardiometabolic risk factors related to MetS.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal do Nível Superior - CAPES (001, 001, 001, 001, 001)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (431053/2016-2, 431053/2016-2, 431053/2016-2, 431053/2016-2)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2018/ 24069-3)
This publication has 45 references indexed in Scilit:
- Lower serum magnesium concentration is associated with diabetes, insulin resistance, and obesity in South Asian and white Canadian women but not menFood & Nutrition Research, 2015
- Visceral Adiposity Index: An Indicator of Adipose Tissue DysfunctionInternational Journal of Endocrinology, 2014
- Harmonizing the Metabolic SyndromeCirculation, 2009
- Exploiting dynamic reaction cell inductively coupled plasma mass spectrometry (DRC-ICP-MS) for sequential determination of trace elements in blood using a dilute-and-shoot procedureAnalytica Chimica Acta, 2009
- HOMA1-IR and HOMA2-IR indexes in identifying insulin resistance and metabolic syndrome: Brazilian Metabolic Syndrome Study (BRAMS)Archives of Endocrinology and Metabolism, 2009
- Diagnosis and management of hypocalcaemiaBMJ, 2008
- I Diretriz Brasileira de Diagnóstico e Tratamento da Síndrome MetabólicaArquivos Brasileiros de Cardiologia, 2005
- International Physical Activity Questionnaire: 12-Country Reliability and ValidityMedicine & Science in Sports & Exercise, 2003
- The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate inapob-lipoprotein-depleted plasma (FERHDL)Clinical Biochemistry, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001